Recent studies show that hyperglycemia activates DNA methyltransferases (DNMTs), inducing hypermethylation of anti-inflammatory gene promoters (e.g., KLF4) and perpetuating inflammation (26), suggesting that glycemic control may modulate plaque phenotypes through epigenetic mechanisms. The gene discussed is KLF4; the disease is Hyperglycemia.